Covered recipient · General Payments record
FRANCISCA VALENZUELA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$1,017.16
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $179.98 | 2 |
| Food and Beverage | $162.90 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $121.86 | 2 |
| Janssen Biotech, Inc. | $94.36 | 2 |
| Amgen Inc. | $38.77 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.67 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.66 | 2 |
| ABBVIE INC. | $15.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.56 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106266372 | CMS |
| Amgen Inc. | $20.41 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117404493 | CMS |
| Amgen Inc. | $18.36 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117404495 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.59 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101316084 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.07 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101316088 | CMS |
| Incyte Corporation | $99.99 | 03/12/2024 | Education | Undisputed | 01/23/2026 | 1141201971 | CMS |
| Incyte Corporation | $21.87 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141192275 | CMS |
| Janssen Biotech, Inc. | $14.37 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078462939 | CMS |
| Janssen Biotech, Inc. | $79.99 | 06/18/2024 | Education | Undisputed | 01/23/2026 | 1078462725 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.62 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152149607 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.05 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152149609 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.